Plain-English translation of NCT05858528 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large European research study that follows people with psoriasis to better understand who develops psoriatic arthritis (joint inflammation related to psoriasis) and what warning signs appear first. Researchers want to find out what happens in the years before someone officially gets diagnosed with psoriatic arthritis, so they can catch and treat the condition earlier and prevent lasting joint damage.
Right now, doctors wait until psoriatic arthritis is fully developed before treating it, but by then joint damage may have already started. This study aims to find the early warning signs—like changes in inflammation markers or subtle symptoms—so doctors can intervene much sooner and possibly prevent the disease from developing at all.
You likely qualify if…
You likely don't qualify if…
You will complete online surveys and share information about your psoriasis, symptoms, and health over time. The study is observational, meaning researchers will monitor your health through your responses rather than giving you any new treatment or medication. You'll be part of a large group of up to 25,000 people across Europe helping doctors learn when and why psoriasis develops into joint disease.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United Kingdom
Collaborators
University College Dublin
Enrollment target
~25,000 participants
Started
June 2023
Primary completion
June 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Laura C Coates, MBChB, PhD
University of Oxford
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.